Olaparib and durvalumab demonstrated strong clinical benefit in mismatch repair proficient advanced or recurrent endometrial cancer
Latest analysis of the results from the DUO-E Phase III trial showed durvalumab plus platinum-based…
Latest analysis of the results from the DUO-E Phase III trial showed durvalumab plus platinum-based…
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is…
A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumours has…
Researchers have developed a genetic test that can identify how patients with triple negative early-stage…
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug,…
Using a combined scanning technique on patients with early-stage breast cancer improved treatment in almost…
A team of international researchers have developed an artificial intelligence (AI) tool that can predict…
The vast majority of young patients given a low-dose boost of radiotherapy to the site…
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their…